Social History Matters–The Impact of Illicit Drug Use on tPA Use and In-Hospital Mortality in Acute Ischemic Stroke
Journal Title: International Neuropsychiatric Disease Journal - Year 2014, Vol 2, Issue 3
Abstract
Aims: The objective of this descriptive study was to compare time to medical evaluation, intravenous tissue plasminogen activator (IV tPA) use, and short-term outcomes in illicit drug users compared to non-users presenting with acute ischemic stroke (AIS). Study Design: This is a retrospective study performed from our stroke registry using de-identified patient information. Place and Duration of Study: Tulane Medical Center Primary Stroke Center (PSC). Consecutive AIS patients presenting to our PSC from July 2008 to December of 2010 were identified from our prospectively collected stroke registry. Methodology: Patients were categorized as toxicology positive (TP) or toxicology negative (TN). We compared baseline characteristics, clinical presentation, tPA use, and short-term outcomes in TP and TN patients. Results: Two hundred and sixty-three patients met inclusion criteria (median age 63, 35.4% female, 66.5% Black). Nearly 40% of toxicology screens were positive. Stroke severity was similar with the median National Institute of Health Stroke Scale (NIHSS) of 6 in both groups; however, a higher proportion of TN patients were treated with IV tPA (32.1% vs. 21.2%). After adjustment for time from last seen normal to emergency department arrival (LSN-to-ED arrival), the odds of being treated with tPA for TP patients were similar to TN patients (OR 0.69, 95% CI 0.36-1.31, p=0.255). After adjustment for age, NIHSS, glucose, and tPA, the odds of in-hospital mortality in TP patients was 3 times that of TN patients (OR 3.17, 95% CI 1.07-9.43, p=0.038). Conclusion: We found that the disparities observed in tPA use were attenuated after adjustment for time from LSN-to-ED arrival, suggesting an area for future intervention. Additionally, we found that TP patients may be at higher risk for in-hospital mortality. Further study on the role of substance abuse in time to ED arrival, tPA use, and outcome in AIS patients is warranted.
Authors and Affiliations
Sheryl Martin-Schild, Matthew H. M. Marx, Karen C. Albright, Amir Shaban, Amelia K. Boehme, T. Mark Beasley
Keywords
Related Articles
- EP ID EP241490
- DOI 10.9734/INDJ/2014/7708
- Views 138
- Downloads 0
Practice Guidelines for Treatment of Somatic Pain and Depression
Background: Somatic pain is often associated with depression. Patients presenting with this combination can be difficult to treat and create a significant financial burden on the medical system. The mechanisms of action...
Sociodemographic and Quality of Life of Patients with Obsessive Compulsive Disorder: A Comparison within Saudi Arabia’s Population
Background: Obsessive Compulsive Disorder (OCD) is a chronic and disabling condition that negatively affects quality of life (QoL) of patients with this disorder attributable to sociodemographic, clinical and illness-spe...
Intergenerational Transmission of Attachment. Family Interactive Dynamics and Psychopathology: What kind of Relationship in Adolescence?
Introduction: This work is an example of empirical research. The aim was to look to the possible transgenerational influence between parents and adolescents attachment bond to their respective parents, infant armonic and...
Dyke-Davidoff-Masson Syndrome- A Rare Cause of Refractory Epilepsy
DDMS is a rare syndrome characterized by seizures, facial asymmetry, contralateral hemiplegia and mental retardation. The characteristic radiologic features are cerebral hemiatrophy with homolateral hypertrophy of the sk...
Resveratrol Reduces C-reactive Protein and Cholesterol in Schizophrenia
Patients with schizophrenia (SZ) are generally found with overweight and obesity and several metabolic disorders. Additionally these patients have less life expectancy, with cardiovascular disease (CVD) the main cause of...